Works by Maus, Joachim

Results: 9

Tramadol SR Formulations: Pharmacokinetic Comparison of a Multiple-Units Dose (Capsule) versus a Single-Unit Dose (Tablet).

Published in:

Clinical Drug Investigation, 2005, v. 25, n. 7, p. 435, doi. 10.2165/00044011-200525070-00002

By:

Cnota, Peter J.;
Nowak, Horst;
Tagarro, Ignacio;
Erb, Katharina;
Schürer, Michael;
Schulz, Hans-Ulrich;
Maus, Joachim

Publication type:

Article

Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy.

Published in:

Diabetes Care, 2011, v. 34, n. 9, p. 2054, doi. 10.2337/dc11-0503

By:

ZIEGLER, DAN;
LOW, PHILLIP A.;
LITCHY, WILLIAM J.;
BOULTON, ANDREW J. M.;
VINIK, AARON I.;
FREEMAN, ROY;
SAMIGULLIN, RUSTEM;
TRITSCHLER, HANS;
MUNZEL, ULLRICH;
MAUS, JOACHIM;
SCHÜTTE, KLEMENS;
DYCK, PETER J.

Publication type:

Article

Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy.

Published in:

Diabetes Care, 2006, v. 29, n. 11, p. 2365, doi. 10.2337/dc06-1216

By:

Ziegler, Dan;
Ametov, Alexander;
Barinov, Alexey;
Dyck, Peter J.;
Gurieva, Irina;
Low, Phillip A.;
Munzel, Ullrich;
Yakhno, Nikolai;
Raz, Itamar;
Novosadova, Maria;
Maus, Joachim;
Samigullin, Rustem

Publication type:

Article

A retrospective database analysis on persistence with inhaled corticosteroid therapy: comparison of two dry powder inhalers during asthma treatment in Germany.

Published in:

International Journal of Clinical Pharmacology & Therapeutics, 2012, v. 50, n. 4, p. 257, doi. 10.5414/CP201665

By:

Voshaar, Thomas;
Kostev, Karel;
Rex, Juliana;
Schröder-Bernhardi, Detlef;
Maus, Joachim;
Munzel, Ullrich

Publication type:

Article

Effect of 4-Year Antioxidant Treatment with α-Lipoic Acid in Diabetic Polyneuropathy: The NATHAN 1 Trial.

Published in:

Diabetes, 2007, v. 56, p. A2

By:

Ziegler, Dan;
Low, Phillip A.;
Boulton, Andrew J.;
Vinik, Aaron I.;
Freeman, Roy;
Samigullin, Rustem;
Tritschler, Hans;
Munzel, Ullrich;
Maus, Joachim;
Schuette, Klemens;
Dyck, Peter J.

Publication type:

Article

Deposition characteristics of a novel intranasal formulation of azelastine hydrochloride plus fluticasone propionate in an anatomic model of the human nasal cavity.

Published in:

Allergy & Asthma Proceedings, 2020, v. 41, n. 4, p. 265, doi. 10.2500/aap.2020.41.200028

By:

Meltzer, Eli O.;
Bachert, Claus;
Mayer, Michael J.;
Kopietz, Ferdinand;
Koltun, Arkady;
Maus, Joachim;
D'Addio, Alexander D.

Publication type:

Article

Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from randomized controlled trials.

Published in:

British Journal of Clinical Pharmacology, 2012, v. 74, n. 1, p. 207, doi. 10.1111/j.1365-2125.2012.04176.x

By:

Hermann, Robert;
Cnota, Peter;
Maus, Joachim

Publication type:

Article

Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray.

Published in:

British Journal of Clinical Pharmacology, 2012, v. 74, n. 1, p. 125, doi. 10.1111/j.1365-2125.2012.04222.x

By:

Derendorf, Hartmut;
Munzel, Ullrich;
Petzold, Ursula;
Maus, Joachim;
Mascher, Hermann;
Hermann, Robert;
Bousquet, Jean

Publication type:

Article

Evaluation of in vitro Penetration of Fluticasone Propionate from MP-AzeFlu and Fluticasone Propionate Nasal Spray Through EpiAirway™606 Tissues Using Vertical Diffusion Cells.

Published in:

Journal of Asthma & Allergy, 2020, v. 13, p. 187, doi. 10.2147/JAA.S238421

By:

Berger, William E;
Bachert, Claus;
Allara, Robert;
Koltun, Arkady;
Kopietz, Ferdinand;
Maus, Joachim G;
D'Addio, Alexander D

Publication type:

Article